Navigation Links
ARRAYit Corporation Receives Purchase Order from ChemBio
Date:11/1/2013

SUNNYVALE, Calif., Nov. 1, 2013 /PRNewswire/ -- ARRAYit Corporation (OTCQB: ARYC) reports that it has received a $72,297 purchase order from ChemBio, the company's high-powered distributor in Moscow, Russia. ChemBio, which is Russia's premiere distributor of life sciences products and services, represents ARRAYit, Corning, Molecular Devices, Nalgene and other leading corporations, providing Russian customers with market information, technical assistance, installation, product support and training. 

ChemBio purchased the patented and proprietary ARRAYit Microarray Platform including a SpotBot® 3 Protein Edition Desktop Personal Microarrayer and 126 additional instruments, tools, kits, reagents and consumables for advanced microarray research and development. 

ARRAYit currently has a worldwide installed customer base of over 390 SpotBot® instruments, representing $8 million in aggregate revenue to the company. ARYC expects to report the sales and earnings from the ChemBio transaction in the current quarter. 

About ARRAYit Corporation                           

ARRAYit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company's innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. ARRAYit's products are used by nearly every major research center in the world.

About Liston Street Pulse   
'/>"/>

SOURCE ARRAYit Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
2. Arrayit on Major Fundraising Drive
3. Genentech Purchases Arrayit Technology
4. ARRAYit Corporation Ships Proprietary Life Sciences Products to Illumina Inc.
5. ARRAYit Corporation Ships Proprietary Life Sciences Products to Google Inc.
6. ARRAYit Corporation Receives $104,000 Purchase Order from the University of California
7. Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
9. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
10. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
11. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 Nektar Therapeutics ... Inc. today announced positive results from its Phase ... investigational, extended half-life recombinant factor VIII (rFVIII) treatment ... (Recombinant)], which met its primary endpoint in reducing ... compared to the on-demand arm. Top-line ...
(Date:8/21/2014)... -- The spinal column is one of the most delicate ... and from the brain through the column control many key ... ailment here can be life altering, and leave the victim ... their body. Though back injury and disease can have an ... options available to make things better than ever before. ...
(Date:8/21/2014)... 21, 2014 /CNW/ - Eisai Limited is pleased to support ... first-of-its-kind comic book available in Canada . ... specifically to educate children and their parents about epilepsy, the ... affecting more than 300,000 Canadians. Eisai is guided by a ... in which the patient is central – there was a ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... 5, 2011 Elekta,s MOSAIQ® Oncology Information System ... No. 1 ranking in the oncology software category from ... Category Leader designation identifies top-rated vendor products in the ... for each market segment. The 2010 ...
... (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaime, ... at the J.P. Morgan 29th Annual Healthcare Conference in San ...   Interested parties may access a live audio ... the BioMarin website, www.BMRN.com .  A replay of the ...
Cached Medicine Technology:Elekta's MOSAIQ Oncology Information System Named Category Leader in '2010 Top 20 Best in KLAS Awards' Report 2Elekta's MOSAIQ Oncology Information System Named Category Leader in '2010 Top 20 Best in KLAS Awards' Report 3BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference 2
(Date:8/22/2014)... Beach, Florida (PRWEB) August 22, 2014 ... for Lasik in Fort Lauderdale at the most affordable ... get better eyesight through their advanced Lasik treatments. LASIK ... worldwide and the Braverman Eye Center has been delivering ... of patients live a glasses-free and contact lenses-free life ...
(Date:8/22/2014)... pain, breathing difficulties, fainting. Each year approx. 265,000 Danes ... serious illness. New research from Aarhus University and Aarhus ... as many as every fourth patient are sent ... symptoms that led to the acute hospitalisation., "Naturally, there ... at the hospital disprove that there is a serious ...
(Date:8/22/2014)... new study from Karolinska Institutet in Sweden provides insight ... touch, vision or sound from different sources and sides ... adequate movements. The findings, which are presented in the ... as a sensory ,hub, integrating various types of sensory ... types. , "The striatum is the main input structure ...
(Date:8/22/2014)... allergy is frequently confused with lactose intolerance. However, these ... body. People with lactose intolerance do not digest lactose ... In the case of the potentially much more dangerous ... milk proteins with its own IgE antibodies. , According ... in Europe suffer from a genuine milk allergy. Less ...
(Date:8/22/2014)... be able to better understand their risks of future ... with different treatments. , The findings, set out in ... are based on the experience of more than 2,000 ... cancer over a period of more than 40 years. ... lymphoma who receive certain types of chemotherapy or radiotherapy ...
Breaking Medicine News(10 mins):Health News:Braverman Eye Center Now Offers Lasik Treatment in Fort Lauderdale at the Most Affordable Fee 2Health News:Many patients are discharged without a diagnosis 2Health News:The striatum acts as hub for multisensory integration 2Health News:Scientists uncover why major cow milk allergen is actually allergenic 2Health News:Scientists map risk of premature menopause after cancer treatment 2
... Support the Long Term Mental Health Needs ... SAN DIEGO, Oct. 24 As the hundreds of,thousands San ... what,happened and deal with the stress of the situation. These ... those directly and,indirectly affected. In the days, weeks and months ...
... Support The Cause In A Variety Of Ways ..., ... the,team,s First Annual Breast Cancer Awareness Night on Friday, October ... Joe Louis Arena. Doors open,at 6 p.m. for the 7:30 ... Hockey Fights Cancer month when all NHL players wore special ...
... MONTREAL, Oct. 24 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX ... to,announce a new two-phase strategy to have a ... for its lead product candidate, the,Hemaseel(R)HMN fibrin sealant, ... This "First-Patient-In" objective is a major milestone ...
... M. Foley, MD,of Memorial Sloan-Kettering Cancer Center in ... University of Utah School of Medicine, received the ... 2007 at the 9th,Annual Josefina Magno Conference on ... of palliative care, the science of pain and,symptom ...
... reduced toxicity, studies find, , , WEDNESDAY, Oct. 24 (HealthDay ... to the standard two-drug regimen used for head and ... reducing the toxicity, two new studies report. , The ... increased survival in both studies and more than doubled ...
... Norway October 24, 2007 - The use of ... increased incidence of reproductive endocrine disorders in both men ... the effects of withdrawal from two common AEDs, carbamazepine ... and female AED users. , The study finds ...
Cached Medicine News:Health News:San Diego Wildfires Mental Health Fund 2Health News:San Diego Wildfires Mental Health Fund 3Health News:Red Wings Host Breast Cancer Awareness Night 2Health News:Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials 2Health News:Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials 3Health News:Two Physicians Recognized for Work in Pain and Symptom Management 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 2Health News:Three Chemo Drugs Better Than Two for Advanced Head/Neck Cancers 3
... WatchMate system is designed to protect a ... and becoming lost or injured. Such residents ... etc., or have suffered a head injury., ... on their wrist or ankle, and points ...
... Smart™ Labels have a direct thermal ... Instruments Tag-it™ HF-I transponder. When processed ... text and other graphics may be ... data is programmed to the RFID ...
... a patent pending solution using Radio ... a smart label to promote patient ... wrong-site, wrong-procedure surgery. This simple to ... orthopedic surgeon with the operating room ...
... Hospitals, correctional facilities, recreational venues ... wristbands to provide automated data capture ... reducing costly and dangerous errors. RFID ... admissions wristbands at entertainment venues as ...
Medicine Products: